CBD

Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Stat
Wed, 02/3/21 - 10:58 am
Jazz Pharma
GW Pharma
M&A
CBD
epilepsy
Epidiolex
Synthetic Cannabinoid Drug For Covid-19 Approved For Phase-1 Clinical Trials
Forbes
Thu, 08/20/20 - 10:44 pm
Tetra BioPharma
CBD
ARDS-003
COVID-19
FDA
clinical trials
Zynerba flunks another PhII trial, all but ending Fragile X hopes
Endpoints
Tue, 06/30/20 - 10:43 am
Zynerba
CBD
Fragile X syndrome
clinical trials
CVS, Walgreens To Lead $23 Billion CBD Market By 2023
Forbes
Fri, 07/12/19 - 12:17 pm
CVS Health
Walgreens Boots Alliance
CBD
Cannabidiol
FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation
CP Wire
Wed, 11/7/18 - 10:11 am
Revive Therapeutics
organ transplantation
Cannabidiol
CBD
Berkeley boy was ‘Patient X’ in first FDA-approved medicine derived from marijuana
San Francisco Chronicle, CA
Mon, 07/9/18 - 10:01 pm
patients
clinical trials
GW Pharma
Epidiolex
seizures
CBD
CBD Oil Products Were Already Readily Available – How is Epidiolex Different?
CP Wire
Mon, 07/2/18 - 04:56 pm
CBD
Epidiolex
GW Pharma
FDA
CBD Oil Products Were Already Readily Available – How is Epidiolex Different?
Tue, 07/3/18 - 02:05 pm
CBD
Epidiolex
GW Pharma
FDA
FDA just approved the first prescription drug derived from marijuana: 4 outstanding questions
Medical Marketing and Media
Tue, 06/26/18 - 10:17 pm
FDA
GW Pharma
Epidiolex
epilepsy
CBD
drug pricing
DEA
This Cannabis-Based Drug Is On the Verge of Making History
Motley Fool
Sun, 05/20/18 - 08:40 pm
GW Pharma
Epidiolex
CBD
Dravet syndrome
Lennox-Gastaut Syndrome
FDA
Why Insys Therapeutics Inc Is Up Double Digits for the Second Straight Day
Motley Fool
Wed, 01/3/18 - 11:55 pm
INSYS Therapeutics
CBD
Prader-Willi Syndrome
FDA grants orphan drug designation to potential Insys brain cancer treatment
Yahoo/AP
Mon, 08/25/14 - 12:00 pm
Insys
orphan drugs
FDA
CBD
glioblastoma multiforme